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Ocular infections with *Chlamydia trachomatis* have been a huge challenge for ophthalmologists, microbiologists, and community health-care workers alike. Trachoma is caused by the ocular serotypes (A, B, Ba, and C) of the bacterium, whereas the other serotypes (D, E, F, G, H, I, J, and K) are associated with inclusion conjunctivitis.\[[@ref1]\] Severe inclusion conjunctivitis, especially in neonates, has high incidence of outcomes generally seen in trachoma.\[[@ref2][@ref3]\]

The study was undertaken to analyze the presence of *C. trachomatis* antigen in patients with different ocular manifestations over the last 8 years (2009--2016).
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Conjunctival swabs from 690 patients referred for detection of chlamydial antigen from 2009 to 2016 were subjected to direct immunofluorescence assay, which is the Centers for Disease Control and Prevention-recommended method for diagnosing *C. trachomatis* infection in ocular specimens.\[[@ref4]\] Chlamydial elementary bodies appeared as round, bright, apple green, fluorescent particles, regular in outline, and 10 or more elementary bodies in a pair of eyes were interpreted as positive.\[[@ref5]\]

Of the 690 patients, 380 were males and 310 were females, ranging in age from 1 year to 80 years. Maximum number of patients was from age group 21 to 30 years and maximum *Chlamydia*-specific antigen positivity was seen in age group 0 to 10 years \[[Table 1](#T1){ref-type="table"}\]. The overall antigen positivity was 45.5% (314 out of 690 patients). From 2009 to 2016, the percentage positivity for *Chlamydia*-specific antigen was 39.4%, 62.2%, 51.8%, 59.0%, 61.8%, 68.6%, 13.4%, and 9.4%, respectively. The highest antigen positivity was seen in 2014 (68.6%) and the least in 2016 (9.4%). The *Chlamydia*-specific antigen positivity in the years 2015 (13.4%) and 2016 (9.4%) was significantly less than in all the previous study years (*P* \< 0.0001); however, there was no significant difference between the antigen positivity of years 2015 and 2016 (*P* = 0.4715) \[[Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}\].
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Demographic distribution of specimens tested and *Chlamydia trachomatis* antigen positivity in the study
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*Chlamydia trachomatis* antigen positivity in patients of different age groups from the years 2009 to 2016
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Based on the clinical diagnosis, patients were divided into four groups -- trachoma group; follicular, acute, or chronic conjunctivitis group; keratoconjunctivitis group; and a group of other eye manifestationssuggestive of chlamydial infections. The difference between antigen positivity in patients having "trachoma" and those having "other eye manifestations" was statistically significant (*P* = 0.0274) \[[Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}\].
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*Chlamydia trachomatis* antigen positivity in patients with different clinical diagnosis from the years 2009 to 2016
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========================

Undiagnosed and hence improperly managed chronic ocular chlamydial infections continue to be a burden in terms of ocular morbidity and vision loss. Stringent surveillance in the coming years is needed to know its burden both in community and in the referral centers with varied ocular manifestations.
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